Marijuana Use: Reclassification To Further Scientific Study Of The Drug Suggested
Marijuana use in medicine is now a growing study. However, the classification of marijuana as a schedule 1 drug which means that there is no accepted medical use and a high potential for abuse is hindering further study of the drug and its medical use. A report released on January 12 by the National Academies of Sciences, Engineering and Medicine calls for expanding research on cannabis and its chemical components called cannabinoids.
There is much to be learned from the study of marijuana and its potential as a drug in the use of treating illnesses. The report recommends reclassifying the schedule 1 study so researchers can have better access to cannabis, making it easier to study. The recommendation from the 16-member committee that authored the report comes at a time where marijuana is more widely accepted.
In a survey from 2015, it is reported that around 22 million people in the U.S. ages 12 and above ingested some form of cannabis mainly as a recreational drug. Around 10 percent reported using the cannabis solely for medical use and 36 percent reported a mix of medical and recreational use of marijuana.
According to Marie McCormick, Harvard T.H. Chan School of Public Health pediatrician, there is a growing acceptance, accessibility and use of cannabis and its derivatives. McCormick and her committee colleagues have studied 10,700 abstracts of studies between January 1, 1999 and August 1, 2016.
According to the studies, marijuana use in medicine has great potential. Evidence indicates that cannabis reduces chronic pain in adults. Multiple sclerosis patients who ingested pills of cannabis derivatives reported temporary relief of muscle spasms. Cannabinoids also help patients tolerate chemotherapy drugs better by reducing nausea and vomiting in adults as reported in an article by ScienceNews.
Sachin Patel, an associate professor of psychiatry at Vanderbilt University School of Medicine who studies cannabinoids as mediators of stress resiliency said that he would be satisfied with a modest change of rescheduling of marijuana. Rescheduling the drug as Schedule II will allow the researchers to get the job done and determine whether the drug is going to be a good medicine. Patel has been researching the drug for 15 years according to an article by PBS Newshour.
Germany Finally Gives 'OK' Signal To Legalizing Medical Marijuana
It has been confirmed that germany is the latest country to have legalized the use of medical marijuana for severe cases on pain medication.
Marijuana Wonders For Multiple Sclerosis: The Use Of Cannabis Sheds Light As It Offers Hope For Patients Inflicted With The Disease, How Is That Possible? Details, Inside
With the continuous emergence of Multiple Sclerosis cases being recorded, how far have experts gone to deplete the problem? What’s the truth behind new claims that the use of marijuana can actually help in lessening the impacts and gradually eradicate the said disease? Find out what health authorities have to say
Medical Marijuana: When It Will Be Accepted?
Voters approved the constitutional amendment in some states of US, but it could be months before the full effect is felt by willingly consumers who has no option to live under usual medication.
CBD Cannabidiol To Be Legalized Soon; Substance Classified As Medicine
CBD Cannabidiol now classified as medicine. New marijuana form can be an answer for cancer, schizophrenia and epilepsy.
Elizabeth Warren 2020: Will Her Fight For Marijuana Business Help?
Due to her fierce effort on calling for banks to support marijuana businesses financially, the Elizabeth Warren 2020 campaign is gaining fast support as the senator announces one of her platforms. Banks are encouraged to see pot businesse as legitimate and a potential money maker for the industry.
MORE IN ITECHPOST
iOS 11 Plagued with Untested Bugs and Early Adoption Pitfalls
Reports of nagging iOS 11 issues have started pouring in just a day after the software was released by Apple on supported devices.
'Tokyo Ghoul' Season 3 Delayed By Its Live-Action Movie? Ken Kenaki Returns With Another Identity?
"Tokyo Ghoul" season 3's release is delayed and there are countless speculations as to why it is being pushed back. Reports claim that the show is to give way to "One Punch Man" and "My Hero Acdemia" but new rumors say that it's lack of materials and storyline as well as its live-action movie are causing the delay.
‘Resident Evil 7: Not A Hero DLC’ First Gameplay Trailer Leaks Online
First gameplay trailer pertaining to RE7: Not A Hero DLC has just leaked on YouTube.